PubRank

Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4338705)

Published in J Am Heart Assoc on November 26, 2014

Authors

James F Meschia1, Jenifer H Voeks2, Pierre P Leimgruber3, Vito A Mantese4, Carlos H Timaran5, David Chiu6, Bart M Demaerschalk7, Virginia J Howard8, Susan E Hughes9, Mary Longbottom1, Annie Green Howard10, Thomas G Brott1

Author Affiliations

1: Department of Neurology, Mayo Clinic, Jacksonville, FL (J.F.M., M.L., T.G.B.).
2: Department of Neurosciences, Medical University of South Carolina, Charleston, SC (J.H.V.).
3: Cardiovascular Diseases and Interventional Cardiology, Providence Spokane Heart Institute, Spokane, WA (P.P.L.).
4: Vascular Surgery, Mercy Clinic, St. Louis, MO (V.A.M.).
5: Vascular Surgery, University of Texas Southwestern Medical Center/VA North Texas Care System, Dallas, TX (C.H.T.).
6: Department of Neurology, The Methodist Hospital, Houston, TX (D.C.).
7: Department of Neurology, Mayo Clinic, Scottsdale, AZ (B.M.D.).
8: Department of Epidemiology, University of Alabama at Birmingham, AL (V.J.H.).
9: Department of Surgery, New Jersey Medical School, Rutgers University, Newark, NJ (S.E.H.).
10: Department of Biostatistics, University of North Carolina at Chapel Hill, NC (A.G.H.).

Associated clinical trials:

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) | NCT00004732

Articles citing this ↘

Symptomatic Carotid Artery Stenosis: Surgery, Stenting, or Medical Therapy? Curr Treat Options Cardiovasc Med (2017) 0.75

Articles cited by this ↗

Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet (1993) 38.49

Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res (2009) 5.87

All-or-none measurement raises the bar on performance. JAMA (2006) 5.17

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet (2004) 4.99

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57

Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71

Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation (2009) 1.83

Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke (2009) 1.75

Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke). J Am Coll Cardiol (2014) 1.56

Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation (2011) 1.51

Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol (2013) 1.40

Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2008) 1.15

Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials. JRSM Cardiovasc Dis (2014) 0.85

The changing risk factor profile of participants enrolled in a secondary stroke prevention trial: Vitamin intervention for stroke prevention. Neuroepidemiology (2006) 0.77